The Takeda Pharmaceutical Co.-led group that is developing a blood plasma treatment for Covid-19 started manufacturing while the late-stage trial to determine whether the hyperimmune globulin therapy works is ongoing, Chief Executive Christophe Weber said.

Johnson & Johnson aims to test the company’s experimental coronavirus vaccine in up to 60,000 volunteers in a late-stage trial scheduled to start in September, according to a U.S. government database of clinical trials.

Mexico aims to conduct late-stage clinical trials for Covid-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said.

Regeneron Pharmaceuticals – with the U.S. National Institute of Allergy and Infectious Diseases (NIAID) – is launching Phase III trials of REGN-COV2, the company’s two-antibody cocktail for the treatment and prevention of COVID-19.

Global coronavirus cases surpassed 6 million, according to a Reuters tally, as Latin America reported a grim milestone of 50,000 deaths from the disease.

Major drugmakers including GlaxoSmithKline and Pfizer face no competition in Mexico from generics readily available elsewhere, partly because of regulatory failings, Mexico’s antitrust body said.

Studies from Britain and Mexico suggest reducing sugar in sweetened drinks or taxing it more to cut consumption can help people limit their calorie intake and lower their risk of developing diabetes, but not by much.   Two separate pieces of research published on Thursday in the British Medical Journal and The Lancet Diabetes & […]

Sanofi’s dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end.   Sanofi Pasteur, the group’s vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, […]

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of Differentiated, Patent-Protected, Fixed-Dose Medicine Combinations, Strong Brand and Commercial Presence and Loyal Customer Base October 01, 2015 08:00 AM Eastern Daylight Time   JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) […]

If you’re a sugar fan, you might have already heard the recent bad news about just how deadly suger-sweetened beverages can be. A study from Tufts University has revealed that one in every 100 deaths from obesity-related diseases is caused by sugary drinks. In fact, they have now been linked to 184,000 deaths across the globe every year. […]